Cargando…

Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology

Since the herb pair Huang Lian-Gan Jiang (HL-GJ) was put forward as conventional compatibility for cold-heat regulation in the middle energizer in the theory of Traditional Chinese Medicine (TCM), their therapeutic effects were observed on the prevention and treatment of intestinal inflammation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Benjiao, Kao, Yanlei, Zhang, Chenglin, Zhao, Huishan, Sun, Fudong, Gong, Zhaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906823/
https://www.ncbi.nlm.nih.gov/pubmed/31871473
http://dx.doi.org/10.1155/2019/2735050
_version_ 1783478426228752384
author Gong, Benjiao
Kao, Yanlei
Zhang, Chenglin
Zhao, Huishan
Sun, Fudong
Gong, Zhaohua
author_facet Gong, Benjiao
Kao, Yanlei
Zhang, Chenglin
Zhao, Huishan
Sun, Fudong
Gong, Zhaohua
author_sort Gong, Benjiao
collection PubMed
description Since the herb pair Huang Lian-Gan Jiang (HL-GJ) was put forward as conventional compatibility for cold-heat regulation in the middle energizer in the theory of Traditional Chinese Medicine (TCM), their therapeutic effects were observed on the prevention and treatment of intestinal inflammation and tumors including colorectal cancer (CRC). However, the active compounds, crucial targets, and related pathways of HL-GJ against CRC remained unclear. The purpose of this research was to establish a comprehensive and systemic approach that could identify the active compounds, excavate crucial targets, and reveal anti-CRC mechanisms of HL-GJ against CRC based on network pharmacology. We used methods including chemical compound screening based on absorption, distribution, metabolism, and excretion (ADME), compound target prediction, CRC target collection, network construction and analysis, Gene Ontology (GO), and pathway analysis. In this study, eight main active compounds of HL-GJ were identified, including Gingerenone C, Isogingerenone B, 5,8-dihydroxy-2-(2-phenylethyl) Chromone, 2,3,4-trihydroxy-benzenepropanoic acid, 3,4-dihydroxyphenylethyl Alcohol Glucoside, 3-carboxy-4-hydroxy-phenoxy Glucoside, Moupinamide, and Obaculactone. HRAS, KRAS, PIK3CA, PDE5A, PPARG, TGFBR1, and TGFBR2 were identified as crucial targets of HL-GJ against CRC. There were mainly 500 biological processes and 70 molecular functions regulated during HL-GJ against CRC (P < 0.001). There were mainly 162 signaling pathways contributing to therapeutic effects (P < 0.001), the top 10 of which included DAP12 signaling, signaling by PDGF, signaling by EGFR, NGF signaling via TRKA from the plasma membrane, signaling by NGF, downstream signal transduction, DAP12 interactions, signaling by VEGF, signaling by FGFR3, and signaling by FGFR4. The study established a comprehensive and systematic paradigm to understand the pharmacological mechanisms of multiherb compatibility such as an herb pair, which might accelerate the development and modernization of TCM.
format Online
Article
Text
id pubmed-6906823
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-69068232019-12-23 Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology Gong, Benjiao Kao, Yanlei Zhang, Chenglin Zhao, Huishan Sun, Fudong Gong, Zhaohua Evid Based Complement Alternat Med Research Article Since the herb pair Huang Lian-Gan Jiang (HL-GJ) was put forward as conventional compatibility for cold-heat regulation in the middle energizer in the theory of Traditional Chinese Medicine (TCM), their therapeutic effects were observed on the prevention and treatment of intestinal inflammation and tumors including colorectal cancer (CRC). However, the active compounds, crucial targets, and related pathways of HL-GJ against CRC remained unclear. The purpose of this research was to establish a comprehensive and systemic approach that could identify the active compounds, excavate crucial targets, and reveal anti-CRC mechanisms of HL-GJ against CRC based on network pharmacology. We used methods including chemical compound screening based on absorption, distribution, metabolism, and excretion (ADME), compound target prediction, CRC target collection, network construction and analysis, Gene Ontology (GO), and pathway analysis. In this study, eight main active compounds of HL-GJ were identified, including Gingerenone C, Isogingerenone B, 5,8-dihydroxy-2-(2-phenylethyl) Chromone, 2,3,4-trihydroxy-benzenepropanoic acid, 3,4-dihydroxyphenylethyl Alcohol Glucoside, 3-carboxy-4-hydroxy-phenoxy Glucoside, Moupinamide, and Obaculactone. HRAS, KRAS, PIK3CA, PDE5A, PPARG, TGFBR1, and TGFBR2 were identified as crucial targets of HL-GJ against CRC. There were mainly 500 biological processes and 70 molecular functions regulated during HL-GJ against CRC (P < 0.001). There were mainly 162 signaling pathways contributing to therapeutic effects (P < 0.001), the top 10 of which included DAP12 signaling, signaling by PDGF, signaling by EGFR, NGF signaling via TRKA from the plasma membrane, signaling by NGF, downstream signal transduction, DAP12 interactions, signaling by VEGF, signaling by FGFR3, and signaling by FGFR4. The study established a comprehensive and systematic paradigm to understand the pharmacological mechanisms of multiherb compatibility such as an herb pair, which might accelerate the development and modernization of TCM. Hindawi 2019-11-29 /pmc/articles/PMC6906823/ /pubmed/31871473 http://dx.doi.org/10.1155/2019/2735050 Text en Copyright © 2019 Benjiao Gong et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gong, Benjiao
Kao, Yanlei
Zhang, Chenglin
Zhao, Huishan
Sun, Fudong
Gong, Zhaohua
Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
title Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
title_full Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
title_fullStr Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
title_full_unstemmed Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
title_short Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
title_sort exploring the pharmacological mechanism of the herb pair “huanglian-ganjiang” against colorectal cancer based on network pharmacology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906823/
https://www.ncbi.nlm.nih.gov/pubmed/31871473
http://dx.doi.org/10.1155/2019/2735050
work_keys_str_mv AT gongbenjiao exploringthepharmacologicalmechanismoftheherbpairhuanglianganjiangagainstcolorectalcancerbasedonnetworkpharmacology
AT kaoyanlei exploringthepharmacologicalmechanismoftheherbpairhuanglianganjiangagainstcolorectalcancerbasedonnetworkpharmacology
AT zhangchenglin exploringthepharmacologicalmechanismoftheherbpairhuanglianganjiangagainstcolorectalcancerbasedonnetworkpharmacology
AT zhaohuishan exploringthepharmacologicalmechanismoftheherbpairhuanglianganjiangagainstcolorectalcancerbasedonnetworkpharmacology
AT sunfudong exploringthepharmacologicalmechanismoftheherbpairhuanglianganjiangagainstcolorectalcancerbasedonnetworkpharmacology
AT gongzhaohua exploringthepharmacologicalmechanismoftheherbpairhuanglianganjiangagainstcolorectalcancerbasedonnetworkpharmacology